Cargando…

Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease – a Longitudinal Analysis

INTRODUCTION: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rieder, Florian, Lopez, Rocio, Franke, Andre, Wolf, Alexandra, Schleder, Stephan, Dirmeier, Andrea, Schirbel, Anja, Rosenstiel, Philip, Dotan, Nir, Schreiber, Stefan, Rogler, Gerhard, Klebl, Frank
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089599/ https://www.ncbi.nlm.nih.gov/pubmed/21573154 http://dx.doi.org/10.1371/journal.pone.0018172

Ejemplares similares

Hemoglobin and Hematocrit Levels in the Prediction of Complicated Crohn's Disease Behavior – A Cohort Study
por: Rieder, Florian, et al.
Publicado: (2014)

Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
por: Kamm, Florian, et al.
Publicado: (2018)

Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
por: Kamm, Florian, et al.
Publicado: (2018)

Efficacy of JAK inhibitors in Crohn’s Disease
por: Rogler, Gerhard
Publicado: (2020)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Factors Promoting Development of Fibrosis in Crohn’s Disease
por: Rogler, Gerhard, et al.
Publicado: (2017)

Whole genome and exome sequencing of monozygotic twins discordant for Crohn’s disease
por: Petersen, Britt-Sabina, et al.
Publicado: (2014)

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort
por: Ditrich, Felicitas, et al.
Publicado: (2020)

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease
por: Reinisch, Walter, et al.
Publicado: (2020)

Fibrostenotic strictures in Crohn’s disease
por: Yoo, Jun Hwan, et al.
Publicado: (2020)

Dysbiotic microbiota interactions in Crohn’s disease
por: Caparrós, Esther, et al.
Publicado: (2021)

Identifying Crohn’s disease signal from variome analysis
por: Wang, Yanran, et al.
Publicado: (2019)

Distinct Longitudinal Changes in Immunoglobulin G N-Glycosylation Associate with Therapy Response in Chronic Inflammatory Diseases
por: Štambuk, Jerko, et al.
Publicado: (2022)

Hallmarks of epithelial to mesenchymal transition are detectable in Crohn’s disease associated intestinal fibrosis
por: Scharl, Michael, et al.
Publicado: (2015)

Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
por: Feagan, Brian G., et al.
Publicado: (2022)

Efficacy of Endoscopic Dilation of Gastroduodenal Crohn’s Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data
por: Bettenworth, Dominik, et al.
Publicado: (2019)

Medical therapy of stricturing Crohn’s disease: what the gut can learn from other organs - a systematic review
por: Bettenworth, Dominik, et al.
Publicado: (2014)

Frequency and Nature of Incidental Extra-Enteric Lesions Found on Magnetic Resonance Enterography (MR-E) in Patients with Inflammatory Bowel Diseases (IBD)
por: Herfarth, Hans H., et al.
Publicado: (2009)

The Role for Dickkopf-Homolog-1 in the Pathogenesis of Crohn’s Disease-Associated Fistulae
por: Frei, Sandra Michaela, et al.
Publicado: (2013)

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines
por: Xu, Ling, et al.
Publicado: (2010)

Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease
por: Dubinsky, Vadim, et al.
Publicado: (2021)

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors
por: Zeitz, Jonas, et al.
Publicado: (2015)

Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015)

Seamless Coupling of Chemical Glycan Release and Labeling for an Accelerated Protein N-Glycan Sample Preparation Workflow
por: Kasim, Mumtaz, et al.
Publicado: (2023)

PTPN2 is Associated with Crohn’s Disease and Its Expression Is Regulated by NKX2-3
por: Yu, Wei, et al.
Publicado: (2012)

Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy
por: Sładek, Małgorzata, et al.
Publicado: (2014)

A novel unconventional T cell population enriched in Crohn’s disease
por: Rosati, Elisa, et al.
Publicado: (2022)

Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype
por: Tavares de Sousa, Helena, et al.
Publicado: (2021)

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)
por: Danese, Silvio, et al.
Publicado: (2019)

A case-only study of gene-environment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology
por: Helbig, Katherine L, et al.
Publicado: (2012)

Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
por: Dehghan, Melody, et al.
Publicado: (2021)

Cell-based glycan arrays for probing glycan–glycan binding protein interactions
por: Briard, Jennie Grace, et al.
Publicado: (2018)

Crohn's disease related strictures in cross‐sectional imaging: More than meets the eye?
por: Sleiman, Joseph, et al.
Publicado: (2022)

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients
por: Greuter, Thomas, et al.
Publicado: (2018)

Role for a Glycan Phosphoinositol Anchor in Fcγ Receptor Synergy
por: Green, Jennifer M., et al.
Publicado: (1997)

Glycan profiling of the gut microbiota by Glycan-seq
por: Oinam, Lalhaba, et al.
Publicado: (2022)

Anti-α-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event
por: Freedman, MS, et al.
Publicado: (2009)

Significance of Postprocedural Contrast Medium Injection after CT-Guided Abscess Drainage
por: Goessmann, Holger, et al.
Publicado: (2023)

Correlation of the Rutgeerts score and recurrence of Crohn’s disease in patients with end ileostomy
por: Chongthammakun, Vasutakarn, et al.
Publicado: (2017)

The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn’s disease
por: Vasseur, Francis, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9p4hsslemimvjv1t0jdbc1k9k9